Maternal health platform Delfina raises $17 million

Delfina has secured $17 million in Series A funding, led by US Venture Partners (USVP), with participation from ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund , along with existing investors. The funding will support expansion across the U.S., AI advancements, and scaling partnerships with payors and providers.

Founded in 2021, Delfina’s platform uses AI-driven predictive analytics to help healthcare providers reduce maternal health risks, including preterm births, NICU admissions, and hypertensive disorders. The company aims to improve outcomes, lower costs, and address disparities in maternal care, particularly for underserved populations.